Granules India transfers CSO Sanjay Kumar to subsidiary CEO role
Granules India Limited transferred Mr. Sanjay Kumar from Chief Strategy Officer to CEO of its subsidiary, Ascelis Peptides Private Limited, effective August 13, 2026. The move aims to provide dedicated leadership for the subsidiary's complex operations. The change was disclosed under SEBI Regulation 30.

*this image is generated using AI for illustrative purposes only.
Granules India Limited has announced the internal transfer of Mr. Sanjay Kumar, Chief Strategy Officer and Senior Management Personnel (SMP), to its wholly owned subsidiary, Ascelis Peptides Private Limited. The transition takes effect on August 13, 2026, with Mr. Kumar assuming the role of Chief Executive Officer at the subsidiary.
The company stated that this move reflects its view that a business of such scale, ambition, and complexity requires dedicated leadership with clear accountability. Mr. Kumar tendered his resignation from the position of Chief Strategy Officer at Granules India Limited on August 12, 2026, pursuant to this internal transfer decision by the management.
Regulatory Disclosure
The intimation was issued pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.
| Particulars | Details |
|---|---|
| Name of SMP | Mr. Sanjay Kumar |
| Reason for Change | Resignation due to internal transfer to wholly owned subsidiary |
| Effective Date | August 13, 2026 |
| New Role | Chief Executive Officer, Ascelis Peptides Private Limited |
Mr. Kumar expressed appreciation for the support and guidance extended by the Board of Directors, the Chairman & Managing Director, and the leadership team during his tenure as Chief Strategy Officer. The Company Secretary and Compliance Officer, Chaitanya Tummala, confirmed the details in the filing.
Historical Stock Returns for Granules
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.84% | +1.47% | -4.47% | +50.47% | +88.43% | +130.21% |
How will the leadership vacuum at Granules India Limited's Chief Strategy Officer role be filled, and will this impact the parent company's strategic roadmap?
What specific growth initiatives or operational challenges at Ascelis Peptides Private Limited prompted the need for dedicated CEO-level leadership?
Will Mr. Sanjay Kumar retain any advisory or board-level responsibilities with Granules India Limited while serving as CEO of the subsidiary?


































